Evolution of the Average Target: Compugen Ltd.

Evolution of the Target Price: Compugen Ltd.

Changes in Analyst Recommendations: Compugen Ltd.

9a51e568902d1fb9b762a9621f18c.XKzHUYbB2CiTUgo0XX3Y1U6xBmmqdEUN49DoSGt5sjk.ZOPxMNeQgkbkZn5bDyiwgj3JbTbTInI9seChDjg9hF4Mmr1oto6yXcNiPg~1e16068a2f3dc492b18460cdfdb8336e
01-07 HC Wainwright Initiates Compugen at Buy With $4 Price Target MT
25-10-13 Compugen Ltd. to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 CI
24-05-20 Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating MT
24-03-08 Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating MT
23-05-16 Oppenheimer Adjusts Compugen's Price Target to $7 From $8, Maintains Outperform Rating MT
23-02-08 Jefferies Downgrades Compugen to Underperform From Hold, Lowers Price Target to $0.50 from $2 MT
23-01-05 EF Hutton Initiates Compugen at Buy With $13 Price Target MT
22-11-15 Oppenheimer Adjusts Compugen PT to $8 From $12, Updates Model to Reflect Evolving Development Strategy; Maintains Outperform Rating MT
22-08-23 Truist Securities Adjusts Compugen's Price Target to $4 From $14, Reiterates Buy Rating MT
22-08-08 JMP Securities Adjusts Price Target on Compugen to $4 From $8, Maintains Market Outperform Rating MT
22-08-05 Oppenheimer Adjusts Compugen Price Target to $12 From $14, Maintains Outperform Rating MT
22-08-05 Stifel Adjusts Compugen's Price Target to $5 From $12, Reiterates Buy Rating MT
22-08-05 Jefferies Downgrades Compugen to Hold From Buy; Price Target is $2 MT
22-02-25 SVB Leerink Adjusts Compugen's Price Target to $9 from $16, Maintains Outperform Rating MT
22-02-25 Oppenheimer Adjusts Compugen's Price Target to $14 From $17, Maintains Outperform Rating MT
21-11-15 Oppenheimer Adjusts Compugen PT to $17 From $19, Maintains Outperform Rating MT
21-04-06 COMPUGEN : SVB Leerink Adjusts Price Target on Compugen to $16 From $19, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+128.86%
+33.05%
+14.91%
+52.64%
+34.39%
+49.16%
-3.63%
+13.38%
+41.54%
Average +40.48%
Weighted average by Cap. +31.97%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.010USD
Average target price
4.600USD
Spread / Average Target
+128.86%
High Price Target
6.000USD
Spread / Highest target
+198.51%
Low Price Target
4.000USD
Spread / Lowest Target
+99.00%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright
Truist Securities
Oppenheimer
Jefferies & Co.
EF Hutton
JMP Securities
Stifel Nicolaus
SVB Leerink
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.010USD
Average target price
4.600USD
Spread / Average Target
+128.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGEN Stock
  4. Consensus Compugen Ltd.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!